These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22619033)

  • 1. Relationship between potential aggregation-prone regions and HLA-DR-binding T-cell immune epitopes: implications for rational design of novel and follow-on therapeutic antibodies.
    Kumar S; Mitchell MA; Rup B; Singh SK
    J Pharm Sci; 2012 Aug; 101(8):2686-701. PubMed ID: 22619033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune Responses to Soluble Aggregates of Amyloidogenic Proteins Involved in Neurodegenerative Diseases: Overlapping Aggregation Prone and Autoimmunogenic regions.
    Kumar S; Thangakani AM; Nagarajan R; Singh SK; Velmurugan D; Gromiha MM
    Sci Rep; 2016 Feb; 6():22258. PubMed ID: 26924748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a promiscuous HLA DR-restricted T-cell epitope derived from the inhibitor of apoptosis protein survivin.
    Piesche M; Hildebrandt Y; Zettl F; Chapuy B; Schmitz M; Wulf G; Trümper L; Schroers R
    Hum Immunol; 2007 Jul; 68(7):572-6. PubMed ID: 17584578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The alternative open reading frame of LAGE-1 gives rise to multiple promiscuous HLA-DR-restricted epitopes recognized by T-helper 1-type tumor-reactive CD4+ T cells.
    Mandic M; Almunia C; Vicel S; Gillet D; Janjic B; Coval K; Maillere B; Kirkwood JM; Zarour HM
    Cancer Res; 2003 Oct; 63(19):6506-15. PubMed ID: 14559844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How do thermophilic proteins resist aggregation?
    Thangakani AM; Kumar S; Velmurugan D; Gromiha MS
    Proteins; 2012 Apr; 80(4):1003-15. PubMed ID: 22389104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell recognition of Neisseria meningitidis class 1 outer membrane proteins. Identification of T cell epitopes with selected synthetic peptides and determination of HLA restriction elements.
    Wiertz EJ; van Gaans-van den Brink JA; Schreuder GM; Termijtelen AA; Hoogerhout P; Poolman JT
    J Immunol; 1991 Sep; 147(6):2012-8. PubMed ID: 1716291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of HLA-DRB1*1501-restricted T-cell epitopes from prostate-specific antigen.
    Klyushnenkova EN; Link J; Oberle WT; Kodak J; Rich C; Vandenbark AA; Alexander RB
    Clin Cancer Res; 2005 Apr; 11(8):2853-61. PubMed ID: 15837732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggregation prone regions in human proteome: Insights from large-scale data analyses.
    Prabakaran R; Goel D; Kumar S; Gromiha MM
    Proteins; 2017 Jun; 85(6):1099-1118. PubMed ID: 28257595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential aggregation-prone regions in complementarity-determining regions of antibodies and their contribution towards antigen recognition: a computational analysis.
    Wang X; Singh SK; Kumar S
    Pharm Res; 2010 Aug; 27(8):1512-29. PubMed ID: 20422267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of HLA class I-restricted T-cell epitopes of islet autoantigen combined with binding and dissociation assays.
    Wu X; Xu X; Gu R; Wang Z; Chen H; Xu K; Zhang M; Hutton J; Yang T
    Autoimmunity; 2012 Mar; 45(2):176-85. PubMed ID: 22260783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
    J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
    Valli A; Sette A; Kappos L; Oseroff C; Sidney J; Miescher G; Hochberger M; Albert ED; Adorini L
    J Clin Invest; 1993 Feb; 91(2):616-28. PubMed ID: 7679413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of HLA-DR-restricted T-cell epitopes derived from human proteinase 3.
    Piesche M; Hildebrandt Y; Chapuy B; Wulf GG; Trümper L; Schroers R
    Vaccine; 2009 Jul; 27(34):4718-23. PubMed ID: 19446593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human acetylcholine receptor presentation in myasthenia gravis. DR restriction of autoimmune T epitopes and binding of synthetic receptor sequences to DR molecules.
    Manfredi AA; Yuen MH; Moiola L; Protti MP; Conti-Tronconi BM
    J Immunol; 1994 Apr; 152(8):4165-74. PubMed ID: 7511671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico binding predictions for identification of HLA-DR-promiscuous regions and epitopes of Mycobacterium tuberculosis protein MPT64 (Rv1980c) and their recognition by human Th1 cells.
    Mustafa AS
    Med Princ Pract; 2010; 19(5):367-72. PubMed ID: 20639660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells.
    Kobayashi H; Nagato T; Takahara M; Sato K; Kimura S; Aoki N; Azumi M; Tateno M; Harabuchi Y; Celis E
    Cancer Res; 2008 Feb; 68(3):901-8. PubMed ID: 18245493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of HLA-DRB1*1501-restricted T-cell epitopes from human prostatic acid phosphatase.
    Klyushnenkova EN; Kouiavskaia DV; Kodak JA; Vandenbark AA; Alexander RB
    Prostate; 2007 Jul; 67(10):1019-28. PubMed ID: 17455230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction of Non-natural Amino Acids Into T-Cell Epitopes to Mitigate Peptide-Specific T-Cell Responses.
    Azam A; Mallart S; Illiano S; Duclos O; Prades C; Maillère B
    Front Immunol; 2021; 12():637963. PubMed ID: 33777029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human TCR as antigen: homologies and potentially cross-reactive HLA-DR2-restricted epitopes within the AV and BV CDR2 loops.
    Vandenbark AA; Culbertson N; Finn T; Barnes D; Buenafe A; Burrows GG; Law S; Chou YK; Offner H
    Crit Rev Immunol; 2000; 20(1):57-83. PubMed ID: 10770270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of helper T-cell epitopes that encompass or lie proximal to cytotoxic T-cell epitopes in the gp100 melanoma tumor antigen.
    Kobayashi H; Lu J; Celis E
    Cancer Res; 2001 Oct; 61(20):7577-84. PubMed ID: 11606397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.